Last reviewed · How we verify
NCT06905236
Kidney Function in Obese Women
NA trial testing walking intervention in Kidney Function Tests in 36 participants. Completed in 22 December 2024.
22 December 2024
Quick facts
| Lead sponsor | Wissal Abassi |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 36 |
| Start date | 23 September 2024 |
| Primary completion | 22 December 2024 |
| Estimated completion | 22 December 2024 |
| Sites | 1 location across Tunisia |
Drugs / interventions tested
- walking intervention
Conditions studied
- Kidney Function Tests — all drugs for Kidney Function Tests →
Sponsor
Wissal Abassi
Who can join
Adults 50 to 60, female only, with Kidney Function Tests. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to investigate the impact of a 10-week moderate intensity interval walking training (MIIWT) program on kidney function markers in obese postmenopausal women. The main question it aims to answer is: Does MIIWT improve kidney function markers in this population? Researchers will compare MIIWT (designed to training group) to non-training intervention (designed to control group) to see if the training program works to improve kidney function markers. Participants in training group will: perform a 10-week MIIWT program, four sessions per week (5 repetitions of 6-min-walking-test (6MWT) at 60-80% of 6MWTdistance measured at baseline, interspersed by 6-min of active recovery between repetitions). Participants in control group will : not perform any physical training and maintain their usual daily activities.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Exercise-Induced Improvements in Renal and Inflammatory Markers in Postmenopausal Women With Obesity: A Randomized Study.
Abassi W, Ouerghi N, Muscella A, Marsigliante S, et al · · 2026 · PMID 42020262 · DOI 10.1016/j.whi.2026.03.006
Verify or expand the search:
- PubMed search for NCT06905236
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Wissal Abassi trials
Trials by the same sponsor.
- NCT07019285 — Interval Training and Plasma Volume Variation · NA · completed
- NCT07074132 — Physical Activity and Quality of Life in Postmenopausal Women · NA · completed
- NCT06809270 — Moderate Intensity Intermittent Walking in Postmenopausal Women · NA · completed
- NCT06793345 — Walking Training Improves Thyroid and Cardiometabolic Markers in Postmenopausal Obesity · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06905236 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wissal Abassi
- Last refreshed: 1 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06905236.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing